Metastatic Triple-Negative Breast Cancer: Chithandizo Chatsopano

 Everest Medicines, kampani ya biopharmaceutical yomwe imayang'ana kwambiri kupanga ndi kugulitsa mankhwala osinthika kuti athe kuthana ndi zosowa zosafunikira m'misika yaku Asia Pacific, yalengeza lero kuti Health Sciences Authority (HSA) yaku Singapore yavomereza Trodelvy® (sacituzumab govitecan kapena SG) yochizira Odwala achikulire omwe ali ndi khansa ya m'mawere yomwe ili ndi khansa ya m'mawere kapena metastatic triple-negative (mTNBC) omwe alandirapo njira ziwiri kapena zingapo zochiritsira zam'tsogolo, chimodzi mwazochizira matenda a metastatic. Ichi ndi chivomerezo choyamba cha mankhwala cha Trodelvy cholandiridwa ndi Everest. Kampani ikuyembekeza zovomerezeka zingapo za Trodelvy m'magawo ake alayisensi mchaka chomwe chikubwera.

"Monga gawo la bizinesi yathu yayikulu yopangira malonda olimba m'misika yaku Asia Pacific, tili okonzeka kufulumizitsa mwachangu gawo lotsatirali lakukula ndi gulu lokhazikika lazamalonda, kuletsa kusiyana pakati pa odwala omwe ali ndi zosowa zachipatala zomwe sizinakwaniritsidwe komanso zoyamba. -in-class biopharmaceutical innovation, "anatero Kerry Blanchard, MD, PhD, Chief Executive Officer wa Everest Medicines. "Monga sitepe yotsatira tikhala tikugwira ntchito limodzi ndi onse okhudzidwa kuti tibweretse Trodelvy kwa amayi aku Singapore omwe ali ndi metastatic TNBC." 

“TNBC ndi 15-20% ya odwala khansa ya m’mawere ku Singapore, ndipo khansa ya m’mawere ndi yomwe imayambitsa imfa ya khansa ya amayi m’dziko muno. Matenda amtunduwu komanso ovuta kuchiza kale anali ndi njira zochepa zochizira, ndipo kupulumuka sikunasinthe pakati pa odwala pafupifupi zaka makumi awiri, "atero a Yang Shi, Chief Medical Officer wa Oncology ku Everest Medicines. Izi zikubweretsa Trodelvy sitepe imodzi pafupi ndi odwala aku Singapore omwe ali ndi metastatic TNBC. "

Kuphatikiza ku Singapore, Everest ikugwirizana kwambiri ndi mabungwe olamulira ku Greater China ndi South Korea kuti awonenso zomwe akufuna ku Trodelvy kwa odwala akuluakulu omwe ali ndi vuto la TNBC losasinthika kapena la metastatic TNBC omwe adalandira njira ziwiri zochiritsira zam'mbuyomu kapena kupitilira apo, imodzi mwa iwo. matenda a metastatic.

• Mu Meyi 2021, bungwe la China National Medical Products Administration linavomereza License yake ya Biologics License Application for Trodelvy ndi kuunikanso patsogolo.

• Mu Disembala 2021, a Ministry of Food and Drug Safety (MFDS) ya ku South Korea inavomereza New Drug Application (NDA) ya Trodelvy. Trodelvy adapatsidwa m'mbuyomu Kusankhidwa Kwachangu komanso Kusankhidwa Kwamankhwala a Orphan ku South Korea.

• Mu Disembala 2021, bungwe la Taiwan Food and Drug Administration lidavomereza NDA yake ya Trodelvy. Trodelvy adapatsidwa kale Udindo Wowunikira Ana ndi Matenda Osauka Kwambiri ku Taiwan.